Global pointof care (POC) drugs of abuse testing market is expected to gain market growthin the forecast period of 2021 to 2028.
Request Sample Copy @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-point-of-care-poc-drugs-of-abuse-testing-market
Drugs of abuse is basically the illegal prescribedsubstances consumed for a non-medical purpose. The point of care (POC) drugs ofabuse testing deals with the detection of illegal substances in the urine,blood, saliva, hair or sweat which is done at a specified testing locationrather than the sample being sent to a laboratory.
The high prevalence of drug abuse in individuals especiallyteenagers and the usage of point of care drugs of abuse testing in sports areprimarily driving the growth of the point of care (POC) drugs of abuse testingmarket. Additionally, the known advantages of point of care drugs of abusetesting such as reduced potential for contamination or deterioration, fewerrequirements to aliquot specimens or store samples and portability are thereason for high adoption and usage of point of care (POC) drugs of abusetesting. On the other hand, the point of care testing devices may not be asreliable and accurate as compared to the laboratory-based testing’s due to highprobability of falser positive or negative results which might restrain theoverall growth of the market. The increasing number of regulatory approvals forand the rising usage of home-based point of care devices is estimated togenerate new opportunities within the forecast period.
Point of care (POC) Drugs of Abuse Testing Market CountryLevel Analysis
Pointof care (POC) drugs of abuse testing market is analysed and market sizeinsights and trends are provided by drugs type, product, sample type andend-user as referenced above.
The countries covered in the point of care (POC) drugs ofabuse testing market report are U.S., Canada and Mexico in North America,Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain,Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore,Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific(APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt,Israel, Rest of Middle East and Africa (MEA) as a part of Middle East andAfrica (MEA), Brazil, Argentina and Rest of South America as part of SouthAmerica.
Request for TOC @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-point-of-care-poc-drugs-of-abuse-testing-market
Healthcare Infrastructure growth Installed base and NewTechnology Penetration
Point of care (POC) drugs of abuse testing market alsoprovides you with detailed market analysis for every country growth inhealthcare expenditure for capital equipment’s, installed base of differentkind of products for point of care (POC) drugs of abuse testing market, impactof technology using life line curves and changes in healthcare regulatoryscenarios and their impact on the point of care (POC) drugs of abuse testingmarket. The data is available for historic period 2010 to 2019.
Competitive Landscape and Point of care (POC) Drugs of AbuseTesting Market Share Analysis
The major players covered in the point of care (POC) drugsof abuse testing market report are uest Diagnostics Incorporated, Abbott,AdvaCare Pharma, Cliawaived Inc., DRUGSCAN, Millennium Health, BD, AgilentTechnologies Inc., Danaher, Bio-Rad Laboratories Inc., Cellavision, JOYSBIO(Tianjin) Biotechnology Co., Ltd, NIHON KOHDEN CORPORATION, Ortho ClinicalDiagnostics, F. Hoffmann-La Roche Ltd, Siemens Healthcare GmbH, SysmexCorporation, Merck KGaA, Cardinal Health, Takara Bio Inc., bioMérieux SA, EnzoLife Sciences Inc., among other domestic and global players. Market share datais available for Global, North America, Europe, Asia-Pacific (APAC), MiddleEast and Africa (MEA) and South America separately. DBMR analysts understandcompetitive strengths and provide competitive analysis for each competitorseparately.
Related Reports
https://www.databridgemarketresearch.com/reports/global-female-sterilization-devices-market
https://www.databridgemarketresearch.com/reports/global-yellow-nail-syndrome-treatment-market
https://www.databridgemarketresearch.com/reports/global-rhabdoid-tumor-treatment-market
